Provided by Tiger Trade Technology Pte. Ltd.

LeMaitre Vascular

86.54
-0.8800-1.01%
Volume:82.05K
Turnover:7.10M
Market Cap:1.96B
PE:37.30
High:87.39
Open:87.39
Low:85.84
Close:87.42
52wk High:105.55
52wk Low:71.42
Shares:22.69M
Float Shares:20.80M
Volume Ratio:0.66
T/O Rate:0.39%
Dividend:0.79
Dividend Rate:0.92%
EPS(TTM):2.32
EPS(LYR):1.93
ROE:15.02%
ROA:7.94%
PB:5.18
PE(LYR):44.84

Loading ...

Here's Why LeMaitre Vascular (NASDAQ:LMAT) Has Caught The Eye Of Investors

Simply Wall St.
·
Feb 06

Wells Fargo Remains a Hold on Lemaitre Vascular (LMAT)

TIPRANKS
·
Nov 26, 2025

LeMaitre Vascular Q3 Sales USD 61.046 Million Vs. IBES Estimate USD 62.2 Million

Reuters
·
Nov 20, 2025

LeMaitre Vascular’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 08, 2025

LeMaitre Vascular Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Nov 08, 2025

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Lemaitre Vascular (LMAT) and Shattuck Labs (STTK)

TIPRANKS
·
Nov 08, 2025

LeMaitre Vascular’s Strong Financial Performance and Growth Prospects Justify Buy Rating and OUTPERFORM Status

TIPRANKS
·
Nov 08, 2025

Lake Street Sticks to Their Buy Rating for Lemaitre Vascular (LMAT)

TIPRANKS
·
Nov 08, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), MBX Biosciences, Inc. (MBX) and Lemaitre Vascular (LMAT)

TIPRANKS
·
Nov 07, 2025

LeMaitre Vascular Issues Amendment to Annual Meeting Voting Results

Reuters
·
Nov 07, 2025

BRIEF-LeMaitre Vascular Q3 Sales USD 61.046 Million Vs. IBES Estimate USD 62.2 Million

Reuters
·
Nov 07, 2025

LeMaitre Vascular Outlook FY Sales $247 Mln - $249 Mln

THOMSON REUTERS
·
Nov 07, 2025

LeMaitre Vascular Outlook FY EPS $2.48 - $2.53

THOMSON REUTERS
·
Nov 07, 2025

LeMaitre Vascular Q3 Adjusted EPS USD 0.62 VS. Ibes Estimate USD 0.57

THOMSON REUTERS
·
Nov 07, 2025

LeMaitre Q3 2025 Financial Results

GlobeNewswire
·
Nov 07, 2025

LeMaitre Vascular Price Target Announced at $108.00/Share by Roth Capital

Dow Jones
·
Nov 06, 2025

Lemaitre Vascular (LMAT) Has a New Rating from Roth MKM

TIPRANKS
·
Nov 05, 2025

LeMaitre Vascular Is Maintained at Outperform by Barrington Research

Dow Jones
·
Oct 15, 2025

Lemaitre Vascular (LMAT) Gets a Buy from Barrington

TIPRANKS
·
Oct 15, 2025

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.
·
Sep 28, 2025